by
DR » Thu May 09, 2024 3:12 pm
We used to test losartan free base at Merck Flint river, before it was sent to another site to turn into K salt. Wavelength used was 220nm for the impurity profile.
Dissolution methods are really easy to develop so it's difficult to understand how it's causing issues.
If I was given losartan tablets for dissolution assay, I'd probably pick a EC-C18 agilent poroshell 50mm, 4.6mm column. Isocratic mode obviously with 0.1% H3PO4/ACN . Do a couple injections to get the RT under 5min through tweaking on MP% and you're set. If you're using a good LC ie. agilent system, you'll have no problems. good luck.
Edit: don't use a 250mm column for a dissolution method. As soon as I saw this, I figured it was developed by a contract lab. Run times are too long. 50mm column are the way to go.
If they're running a monograph method, they have to stick to the monograph's rules regarding changes in column dimensions, flow rates, MP composition and injection volume.
A poroshell column (especially a short one) may not work at all given its limited capacity and the possibility of needing a fairly high amount of analyte (large injection volume) if it has a weak chromophore.
Inertsil ODS-3 is an excellent stationary phase, though you may be able to at least go with a shorter, narrower bore version and meet USP requirements once you've adjusted your flow rate and (maybe) injection volume.
RE: the ease of dissolution method development - It's usually not difficult to develop a chromatographic method to show a fairly narrow range of analyte concentration from dissolution samples, but making sure that a dissolution method is discriminating and appropriate for a given API can be a challenge, especially when encountering extremes of API solubility in aqueous media...